Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Krisztian Homicsko

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
Current Research in Toxicology|April 25, 2025
iPSC-derived and Patient-Derived Organoids: Applications and challenges in scalability and reproducibility as pre-clinical modelsElisa Heinzelmann, Francesco Piraino, Mariana Costa, et al.
Cancer Cell|September 16, 2022
Cancer cell autophagy, reprogrammed macrophages, and remodeled vasculature in glioblastoma triggers tumor immunityAgnieszka Chryplewicz, Julie Scotton, Mélanie Tichet, et al.
Journal for Immunotherapy of Cancer|October 26, 2022
First communication on the efficacy of combined <sup>177</sup>Lutetium-PSMA with immunotherapy outside prostate cancerAntonia Digklia, Sarah Boughdad, Krisztian Homicsko, et al.
Frontiers in Oncology|April 18, 2025
Case Report: Lasting complete response to pembrolizumab in mismatch repair-deficient cardiac sarcoma: a genomic characterizationDaniela A Ferraro, Bettina Bisig, David C Rotzinger, et al.
Nature Biotechnology|July 2, 2024
Patient-derived mini-colons enable long-term modeling of tumor-microenvironment complexityL Francisco Lorenzo-Martín, Nicolas Broguiere, Jakob Langer, et al.
Cancer Biology & Therapy|March 27, 2023
Deep and lasting response and acquired resistance to BRAFV600E targeting in a low-grade ovarian cancer patientSandro Anchisi, Anita Wolfer, Bettina Bisig, et al.
Cancer Discovery|April 29, 2021
Cancer Cells Retrace a Stepwise Differentiation Program during Malignant ProgressionSadegh Saghafinia, Krisztian Homicsko, Annunziata Di Domenico, et al.
Cancer Discovery|April 27, 2025
HPV16-Expressing Tumors Release Multiple IL-1 Ligands to Orchestrate Systemic Immunosuppression Whose Disruption Enables Efficacy of a Therapeutic VaccineMorgane Lecointre, Jérémy Guillot, Rachel Marcone, et al.
Cancers|January 25, 2025
In Vitro Evaluation of the Safety and Efficacy of <i>Cibisatamab</i> Using Adult Stem Cell-Derived Organoids and Colorectal Cancer SpheroidsVictor Anstett, Elisa Heinzelmann, Francesco Piraino, et al.
British Journal of Cancer|February 14, 2018
Strategies for clinical development of monoclonal antibodies beyond first-in-human trials: tested doses and rationale for dose selectionMarie Viala, Marie Vinches, Marie Alexandre, et al.
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
Current Research in Toxicology|April 25, 2025
iPSC-derived and Patient-Derived Organoids: Applications and challenges in scalability and reproducibility as pre-clinical modelsElisa Heinzelmann, Francesco Piraino, Mariana Costa, et al.
Cancer Cell|September 16, 2022
Cancer cell autophagy, reprogrammed macrophages, and remodeled vasculature in glioblastoma triggers tumor immunityAgnieszka Chryplewicz, Julie Scotton, Mélanie Tichet, et al.
Journal for Immunotherapy of Cancer|October 26, 2022
First communication on the efficacy of combined <sup>177</sup>Lutetium-PSMA with immunotherapy outside prostate cancerAntonia Digklia, Sarah Boughdad, Krisztian Homicsko, et al.
Frontiers in Oncology|April 18, 2025
Case Report: Lasting complete response to pembrolizumab in mismatch repair-deficient cardiac sarcoma: a genomic characterizationDaniela A Ferraro, Bettina Bisig, David C Rotzinger, et al.
Nature Biotechnology|July 2, 2024
Patient-derived mini-colons enable long-term modeling of tumor-microenvironment complexityL Francisco Lorenzo-Martín, Nicolas Broguiere, Jakob Langer, et al.
Cancer Biology & Therapy|March 27, 2023
Deep and lasting response and acquired resistance to BRAFV600E targeting in a low-grade ovarian cancer patientSandro Anchisi, Anita Wolfer, Bettina Bisig, et al.
Cancer Discovery|April 29, 2021
Cancer Cells Retrace a Stepwise Differentiation Program during Malignant ProgressionSadegh Saghafinia, Krisztian Homicsko, Annunziata Di Domenico, et al.
Cancer Discovery|April 27, 2025
HPV16-Expressing Tumors Release Multiple IL-1 Ligands to Orchestrate Systemic Immunosuppression Whose Disruption Enables Efficacy of a Therapeutic VaccineMorgane Lecointre, Jérémy Guillot, Rachel Marcone, et al.
Cancers|January 25, 2025
In Vitro Evaluation of the Safety and Efficacy of <i>Cibisatamab</i> Using Adult Stem Cell-Derived Organoids and Colorectal Cancer SpheroidsVictor Anstett, Elisa Heinzelmann, Francesco Piraino, et al.
British Journal of Cancer|February 14, 2018
Strategies for clinical development of monoclonal antibodies beyond first-in-human trials: tested doses and rationale for dose selectionMarie Viala, Marie Vinches, Marie Alexandre, et al.
Pageof 6